Groove Botanicals (GRVE) 10-Q 14 Nov 24 2025 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Sep. 30, 2024	Oct. 16, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--03-31
Entity File Number	000-23476
Entity Registrant Name	GROOVE BOTANICALS, INC.
Entity Central Index Key	0000918573
Entity Tax Identification Number	84-1168832
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	310 Fourth Avenue South
Entity Address, Address Line Two	Suite 7000
Entity Address, City or Town	Minneapolis
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55415
City Area Code	612
Local Phone Number	315-5068
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		59,643,062

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2024	Mar. 31, 2024
Current Assets:
Cash	$ 6,133	$ 1,688
Accounts Receivable
Prepaid Expenses	4,992	454
Total Current Assets	11,125	2,142
TOTAL ASSETS	11,125	2,142
Current Liabilities:
Accounts Payable and Accrued Liabilities	74,614	91,172
Interest Payable
Related Party Payable	544,970	453,057
Convertible Notes Payable
Dividends payable	267,705	178,470
Dividends payable, related party	60,000	40,000
Total Current Liabilities	947,289	762,699
Total Liabilities	947,289	762,699
Stockholders’ Equity
Common Stock, $0.001 par value, 200,000,000 shares authorized. and 59,643,062 shares issued and outstanding as of September 30, 2024, and March 31, 2024, respectively	59,643	59,643
Additional paid-in capital	34,026,869	34,026,869
Accumulated deficit	(35,022,884)	(34,847,277)
Total stockholder’s equity	(936,164)	(760,557)
TOTAL LIABILITIES AND STOCKHOLDER’S DEFICIT	11,125	2,142
Series A Preferred Stock [Member]
Current Liabilities:
Dividends payable	60,000	40,000
Stockholders’ Equity
Preferred stock, value	10	10
Series B Preferred Stock [Member]
Current Liabilities:
Dividends payable	267,705	178,470
Stockholders’ Equity
Preferred stock, value	$ 198	$ 198

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2024	Mar. 31, 2024
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	59,643,062	59,643,062
Common stock, shares outstanding	59,643,062	59,643,062
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.10	$ 0.10
Preferred stock, shares authorized	100	100
Preferred stock, shares issued	100	100
Preferred stock, shares outstanding	100	100
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.10	$ 0.10
Preferred stock, shares authorized	2,000	2,000
Preferred stock, shares issued	1,983	1,983
Preferred stock, shares outstanding	1,983	1,983

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Expenses:
Selling, General and Administrative Expenses	$ 18,332	$ 21,852	$ 34,931	$ 38,816
Rent	3,591	4,644	8,235	9,288
Legal and Professional Expenses	7,410	1,298	21,956	25,368
Consulting Expense	500		1,250	78,300
Total Operating Expenses	29,833	27,795	66,372	151,772
Operating Loss	(29,833)	(27,795)	(66,372)	(151,772)
Other Income (Expense)
Interest Expense		(2,250)		(4,500)
Total Other Income (Expense)		(2,250)		(4,500)
Net (Loss)	(29,833)	(30,045)	(66,372)	(156,272)
Dividends on Preferred Stock	54,618	54,618	109,235	109,235
Loss attributed to common stockholders	$ (84,452)	$ (84,663)	$ (175,607)	$ (265,507)
Basic loss per common share	$ 0	$ 0	$ 0	$ 0
Diluted loss per common share	$ 0	$ 0	$ 0	$ 0
Weighted average common shares outstanding Basic	59,643,062	58,643,062	59,643,062	58,561,905
Weighted average common shares outstanding diluted	59,643,062	58,643,062	59,643,062	58,561,905

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock Series A Stock [Member]	Preferred Stock Series B Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2023	$ 10	$ 198	$ 57,643	$ 33,930,569	$ (34,426,718)	$ (438,298)
Beginning balance, shares at Mar. 31, 2023	100	1,983	57,643,062
Issuance of Stock for Consulting			$ 1,000	77,300		78,300
Issuance of Stock for Consulting, shares			1,000,000
Accrued dividend to related party					(54,618)	(54,618)
Net (loss)					(126,227)	(126,227)
Ending balance, value at Jun. 30, 2023	$ 10	$ 198	$ 58,643	34,007,869	(34,607,563)	(540,843)
Ending balance, shares at Jun. 30, 2023	100	1,983	58,643,062
Accrued dividend to related party, Series A Preferred Stock					(10,000)	(10,000)
Accrued dividend to Series B Preferred Stock					(44,617)	(44,617)
Net (loss)					(30,045)	(30,045)
Ending balance, value at Sep. 30, 2023	$ 10	$ 198	$ 58,643	34,007,869	(34,692,225)	(625,505)
Ending balance, shares at Sep. 30, 2023	100	1,983	58,643,062
Beginning balance, value at Mar. 31, 2024	$ 10	$ 198	$ 59,643	34,026,869	(34,847,277)	(760,557)
Beginning balance, shares at Mar. 31, 2024	100	1,983	59,643,062
Accrued dividend to related party					(54,617)	(54,617)
Net (loss)					(36,539)	(36,539)
Ending balance, value at Jun. 30, 2024	$ 10	$ 198	$ 59,643	34,026,869	(34,938,433)	(851,713)
Ending balance, shares at Jun. 30, 2024	100	1,983	59,643,062
Accrued dividend to related party, Series A Preferred Stock					(10,000)	(10,000)
Accrued dividend to Series B Preferred Stock					(44,618)	(44,618)
Net (loss)					(29,833)	(29,833)
Ending balance, value at Sep. 30, 2024	$ 10	$ 198	$ 59,643	$ 34,026,869	$ (35,022,884)	$ (936,164)
Ending balance, shares at Sep. 30, 2024	100	1,983	59,643,062

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flow From Operating Activities
Net Loss	$ (66,372)	$ (156,272)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock Issued for Outside Services		78,300
Accrued Interest		4,500
Accrued Payroll	24,000	24,000
Changes in working capital
Increase (Decrease) in Prepaid Expenses	(4,538)	88
Increase (Decrease) in Accounts Payable and Accrued Liabilities	(16,558)	(1,438)
Net Cash Used in Operating Activities	(63,468)	(50,822)
Cash Flow From Investing Activities
Net Cash From Investing Activities
Cash Flow From Financing Activities
Funds received from Related Party	67,913	49,102
Net Cash From Financing Activities	67,913	49,102
Net Change in Cash	4,445	(1,720)
Cash at Beginning of Period	1,688	4,566
Cash at End of Period	6,133	2,846
Net cash paid for:
Interest
Income Taxes

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (29,833)	$ (30,045)	$ (66,372)	$ (156,272)

Insider Trading Arrangements

Insider Trading Arrangements	6 Months Ended
	Sep. 30, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

ORGANIZATION AND OPERATIONS

ORGANIZATION AND OPERATIONS	6 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
ORGANIZATION AND OPERATIONS	NOTE 1 - ORGANIZATION AND OPERATIONS Current Operations Groove Botanicals, Inc. (the “Company”), (formerly known as Avalon Oil & Gas, Inc.), was originally incorporated in Colorado on April 25, 1991, under the name Snow Runner (USA), Inc. The Company was the general partner of Snow Runner (USA) Ltd.; a Colorado limited partnership to sell proprietary snow skates under the name “Sled Dogs” which was dissolved in August 1992. In late 1993, the Company relocated its operations to Minnesota and in January 1994 changed our name to Snow Runner, Inc. In November 1994 we changed our name to the Sled Dogs Company. On May 25, 1999, we filed articles of merger with Xdogs.com Inc., changing our state of domicile to Nevada. On June 22, 2005, the Corporation changed our name from XDOGS.com, Inc. to Avalon Oil and Gas, Inc. On May 14, 2018, the Corporation changed our name from Avalon Oil and Gas, Inc., to Groove Botanicals, Inc. Until August 2, 2021, when we filed a 15-12B to suspend duty to file reports under sections 13 and 15(d) of the securities exchange act of 1934, we were a reporting company. Subsequently, on September 14, 2023 we filed a Form 10 with the Securities and Exchange Commission, which became effective 60 days later. Since inception we have operated, unsuccessfully, in various different industries. Currently, we plan to assemble a portfolio of early-stage EV Battery Technologies developed from Universities in Norway, Sweden and Finland, and seek grants from the State of Minnesota Department of Economic Development to find and identify corporate partners to commercialize these technologies and ultimately produce revenues for the Company. The Company does not currently own any patents or technologies related to the EV battery industry, and the process to acquire patents and technologies can be costly, and as such, the Company is not guaranteed to acquire any such patents. Management believes that the technologies available in the specialized energy industry present a stable business model with high growth potential and we are actively working towards an impactful acquisition in this space. On July 29, 2024, Mr. Douglas Barton resigned as a director of the Company. Mr. Barton did not resign due to any dispute or disagreement with the Company or its practices.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United Stated of America (“U.S. GAAP”) for financial information. Accordingly, they include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The consolidated financial statements include all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary in order to make the financial statements not misleading. The consolidated balance sheets as of June 30, 2024 and 2023, were derived from the Company’s consolidated financial statements at that date. Basis of Consolidation The Company’s consolidated financial statements include the accounts of Groove Botanicals, Inc., and its two 100% controlled non-operating subsidiaries formed in Wyoming, Biotrex, Inc., and Maxidyne, Inc. Intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the valuation of derivative liability, stock compensation and beneficial conversion feature expenses. Actual results could differ from those estimates. Net Loss Per Share The Company computes net income (loss) per share in accordance with ASC 260, Earning per Share. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As the Company has continued to report operating losses for the periods covered by this report, the impact of potentially dilutive securities would be antidilutive and therefore is not presented. Income Taxes The Company is taxed as a C corporation for income tax purposes. The Company accounts for income taxes under the liability method, and deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying values of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. A valuation allowance is provided on deferred tax assets if it is determined that it is more likely than not that the deferred tax asset will not be realized. The Company records interest, net of any applicable related income tax benefit, on potential income tax contingencies as a component of income tax expense. The Company records tax positions taken or expected to be taken in a tax return based upon the amount that is more likely than not to be realized or paid, including in connection with the resolution of any related appeals or other legal processes. Accordingly, the Company recognizes liabilities for certain unrecognized tax benefits based on the amounts that are more likely than not to be settled with the relevant taxing authority. The Company recognizes interest and/or penalties related to unrecognized tax benefits as a component of income tax expense. Beneficial Conversion Feature The Company measures certain convertible debt using a nondetachable conversion feature known as a beneficial conversion feature, or BCF. A convertible instrument contains a BCF when the conversion price is less than the fair value of the shares into which the instrument is convertible at the commitment date. From time to time, the Company may issue convertible notes that may contain a beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method. Debt Issuance Cost Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the balance sheet. In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20 that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. Two methods of transition were permitted upon adoption: full retrospective and modified retrospective. The Company has yet to adopt ASC 2020-06. The accounting impact will be a reclassification from Additional Paid-In Capital to Retained Earnings. The Company adopted ASC 2020-06 as of April 1, 2023. Recently Issued Accounting Pronouncements In November 2023, the FASB issued Accounting Standards Update 2023-07, Segment Reporting—Improvements to Reportable Segment Disclosures In December 2023, the FASB issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures In March 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate Related Disclosures for Investors

GOING CONCERN

GOING CONCERN	6 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 3 - GOING CONCERN The accompanying consolidated financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the consolidated financial statements, the Company has incurred recurring net losses since its inception and has raised limited capital. The Company had a net loss of $ 66,372 156,272 35,022,884 34,847,277

CASH

CASH	6 Months Ended
	Sep. 30, 2024
Cash and Cash Equivalents [Abstract]
CASH	NOTE 4 – CASH The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. As of September 30, 2024, the Company’s cash consisted of non-restricted cash.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 – RELATED PARTY TRANSACTIONS The Company had related party payables of $ 544,970 453,057 Mr. Kent Rodriguez agreed to extend the term of this Employment Contract, which expired on March 31, 2024, for a further two-year term to March 31, 2026, retroactive to April 1, 2024, on the same terms and conditions. These payables and cash advances accrue no interest and have no maturity date. 12,000 24,000 During each of the three-and six-month periods ended September 30, 2024, and 2023, the Company accrued $ 10,000 20,000

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	6 Months Ended
	Sep. 30, 2024
Disclosure Convertible Notes Payable Abstract
CONVERTIBLE NOTES PAYABLE	NOTE 6 – CONVERTIBLE NOTES PAYABLE Convertible notes payable consists of a $ 40,000 10% June 30, 2022 40,000 60,000 March 7, 2023 10% 0.02 On July 18, 2022, a Letter Agreement was drafted between the Company and the debtholder, which establishes the settlement of these debts once the Company’s Form 10 goes effective. On January 23, 2023 the Company and the convertible note holder mutually agreed to settle any and all amounts owed pursuant to 1) the Consulting Agreement and Convertible Promissory Note in the amount of $ 40,000 60,000 $ 10,000 40,000 71,242 21,242 As of September 30, 2024 and March 31, 2024, the balance of the convertible note was $ 0

PREFERRED STOCK

PREFERRED STOCK	6 Months Ended
	Sep. 30, 2024
Equity [Abstract]
PREFERRED STOCK	NOTE 7 – PREFERRED STOCK The Company is authorized to issue 1,000,000 shares of Preferred Stock. We have authorized 100 2,000 0.10 100 1,983 Series A Preferred Stock holds designations of cash dividends at the rate of 8% of the amount per share of Series A Preferred Stock per annum in the form of “Preferred Dividends”, voting rights on an as-converted to Common Stock basis, liquidation preferences, and conversion rights in which each share of Series A Preferred Stock shall, upon conversion, represent 0.51% of the then “Fully-Diluted Shares Outstanding” of the Company. On January 12, 2018, our Board of Directors agreed to amend Designation of the Series A Convertible Preferred Stock be amended by changing the ratio for conversion, in Article IV, subparagraph (a), from 0.4% to 0.51% so that upon conversion the number of shares of common stock to be exchanged shall equal 51% of then issued and outstanding common stock. In addition, on January 12, 2018, the Company and the Series A Holder agreed to forgive all accrued interest to date on the Series A, and to pause any accruals until April 1, 2023. The Series A Convertible Preferred Stock carries liquidating preference, over all other classes of stock, equal to the amount paid for the stock plus any unpaid dividends. Currently the value of the liquidation preference is $ 500,000 5,000 10,000 20,000 60,000 40,000 Series B Preferred Stock holds designations of being ranked junior to the Series A Preferred Stock, cash dividends at the rate of 9% of the amount per share of Series B Preferred Stock per annum in the form of “Preferred Dividends”, a dividend received deduction for federal income tax purposes, liquidation preferences ranked junior to the Series A Preferred Stock, redemption of the Series B Preferred Stock by the Company at 105% of the Stated Value, plus accrued and unpaid Dividends, if prior to the two year anniversary of the Issuance Date, or at 100% of the State Value, plus accrued and unpaid Dividends, if on or after the two year anniversary of the Issuance Date, no voting rights, and right to notice of certain corporate action. All accrued dividends on the Series B were settled through March 31, 2023, and none remained outstanding at March 31, 2023. Dividends began to accrue on the Series B Preferred Stock as of April 1, 2023. During each of the three and six-month periods ended September 30, 2024 and 2023, the holders of the Series B preferred shares accrued $ 44,617 89,235 267,705 178,470

COMMON STOCK

COMMON STOCK	6 Months Ended
	Sep. 30, 2024
Equity [Abstract]
COMMON STOCK	NOTE 8 – COMMON STOCK The Company is authorized to issue 200,000,000 0.001 The Company had 59,643,062 Shares issued in the six months ended September 30, 2024: There were no shares issued during the six-month period ended September 30, 2024. Shares issued in the six months ended September 30, 2023: On April 15, 2023, the Company issued 1,000,000 0.0783

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 9: COMMITMENTS AND CONTINGENCIES As of September 30, 2024, the Company has a month-to-month verbal lease agreement with the landlord, in which the Company pays $1,200 on a monthly basis.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855 and has determined that no material subsequent events exist through the date of this filing other than as set out below.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United Stated of America (“U.S. GAAP”) for financial information. Accordingly, they include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The consolidated financial statements include all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary in order to make the financial statements not misleading. The consolidated balance sheets as of June 30, 2024 and 2023, were derived from the Company’s consolidated financial statements at that date.
Basis of Consolidation	Basis of Consolidation The Company’s consolidated financial statements include the accounts of Groove Botanicals, Inc., and its two 100% controlled non-operating subsidiaries formed in Wyoming, Biotrex, Inc., and Maxidyne, Inc. Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the valuation of derivative liability, stock compensation and beneficial conversion feature expenses. Actual results could differ from those estimates.
Net Loss Per Share	Net Loss Per Share The Company computes net income (loss) per share in accordance with ASC 260, Earning per Share. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As the Company has continued to report operating losses for the periods covered by this report, the impact of potentially dilutive securities would be antidilutive and therefore is not presented.
Income Taxes	Income Taxes The Company is taxed as a C corporation for income tax purposes. The Company accounts for income taxes under the liability method, and deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying values of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. A valuation allowance is provided on deferred tax assets if it is determined that it is more likely than not that the deferred tax asset will not be realized. The Company records interest, net of any applicable related income tax benefit, on potential income tax contingencies as a component of income tax expense. The Company records tax positions taken or expected to be taken in a tax return based upon the amount that is more likely than not to be realized or paid, including in connection with the resolution of any related appeals or other legal processes. Accordingly, the Company recognizes liabilities for certain unrecognized tax benefits based on the amounts that are more likely than not to be settled with the relevant taxing authority. The Company recognizes interest and/or penalties related to unrecognized tax benefits as a component of income tax expense.
Beneficial Conversion Feature	Beneficial Conversion Feature The Company measures certain convertible debt using a nondetachable conversion feature known as a beneficial conversion feature, or BCF. A convertible instrument contains a BCF when the conversion price is less than the fair value of the shares into which the instrument is convertible at the commitment date. From time to time, the Company may issue convertible notes that may contain a beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.
Debt Issuance Cost	Debt Issuance Cost Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the balance sheet. In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20 that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. Two methods of transition were permitted upon adoption: full retrospective and modified retrospective. The Company has yet to adopt ASC 2020-06. The accounting impact will be a reclassification from Additional Paid-In Capital to Retained Earnings. The Company adopted ASC 2020-06 as of April 1, 2023.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the FASB issued Accounting Standards Update 2023-07, Segment Reporting—Improvements to Reportable Segment Disclosures In December 2023, the FASB issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures In March 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate Related Disclosures for Investors

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 29,833	$ 30,045	$ 66,372	$ 156,272
Accumulated deficit	$ 35,022,884		$ 35,022,884		$ 34,847,277

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Jul. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2024
Related Party Transaction [Line Items]
Related party payment outstanding		$ 544,970		$ 544,970		$ 453,057
Accrued preferred dividends		54,618	$ 54,618	109,235	$ 109,235
Series A Preferred Stock [Member]
Related Party Transaction [Line Items]
Accrued preferred dividends		10,000	10,000	20,000	20,000
Chief Executive Officer [Member] | Kent Rodriguez [Member]
Related Party Transaction [Line Items]
Description of employment agreement	Mr. Kent Rodriguez agreed to extend the term of this Employment Contract, which expired on March 31, 2024, for a further two-year term to March 31, 2026, retroactive to April 1, 2024, on the same terms and conditions. These payables and cash advances accrue no interest and have no maturity date.
Accrued salary		$ 12,000	$ 24,000	$ 12,000	$ 24,000

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)			1 Months Ended		12 Months Ended
	Mar. 07, 2022	Mar. 05, 2021	Dec. 31, 2023	Jan. 24, 2023	Mar. 31, 2024	Sep. 30, 2024
Convertible Promissory Note [Member]
Short-Term Debt [Line Items]
Debt interest rate		10%
Maturity date		Jun. 30, 2022
Debt instrument principal amount		$ 40,000
Convertible Promissory Note [Member] | Third Party [Member]
Short-Term Debt [Line Items]
Convertible promissory note		$ 40,000
Convertible Promissory Note 2 [Member]
Short-Term Debt [Line Items]
Convertible promissory note	$ 60,000
Debt interest rate	10%
Maturity date	Mar. 07, 2023
Debt instrument conversion price	$ 0.02
Convertible note					$ 0	$ 0
Convertible Promissory Note 2 [Member] | Settlement Agreement [Member]
Short-Term Debt [Line Items]
Settlement payment			$ 40,000	$ 10,000
Gain on settlement of debt					71,242
Interest forgiven					$ 21,242

PREFERRED STOCK (Details Narrat

PREFERRED STOCK (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2024
Class of Stock [Line Items]
Liquidation preference, value	$ 500,000		$ 500,000
Liquidation preference per share	$ 5,000		$ 5,000
Accrued preferred dividends	$ 54,618	$ 54,618	$ 109,235	$ 109,235
Dividends payable	$ 267,705		$ 267,705		$ 178,470
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	100		100		100
Preferred stock, par value	$ 0.10		$ 0.10		$ 0.10
Preferred stock, shares issued	100		100		100
Preferred stock, shares outstanding	100		100		100
Accrued preferred dividends	$ 10,000	10,000	$ 20,000	20,000
Dividends payable	$ 60,000		$ 60,000		$ 40,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	2,000		2,000		2,000
Preferred stock, par value	$ 0.10		$ 0.10		$ 0.10
Preferred stock, shares issued	1,983		1,983		1,983
Preferred stock, shares outstanding	1,983		1,983		1,983
Accrued preferred dividends	$ 44,617	$ 44,617	$ 89,235	$ 89,235
Dividends payable	$ 267,705		$ 267,705		$ 178,470

COMMON STOCK (Details Narrative

COMMON STOCK (Details Narrative) - $ / shares	1 Months Ended
	Apr. 15, 2023	Sep. 30, 2024	Mar. 31, 2024
Offsetting Assets [Line Items]
Common stock, shares authorized		200,000,000	200,000,000
Common stock, par value		$ 0.001	$ 0.001
Common stock, shares issued		59,643,062	59,643,062
Common stock, shares outstanding		59,643,062	59,643,062
Consulting Agreement [Member]
Offsetting Assets [Line Items]
Stock issued in exchange for services	1,000,000
Share Price	$ 0.0783

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)	6 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Verbal lease agreement description	Company has a month-to-month verbal lease agreement with the landlord, in which the Company pays $1,200 on a monthly basis.